Skip to Content
Merck
  • Impaired degranulation and proliferative capacity of Mycobacterium tuberculosis-specific CD8+ T cells in HIV-infected individuals with latent tuberculosis.

Impaired degranulation and proliferative capacity of Mycobacterium tuberculosis-specific CD8+ T cells in HIV-infected individuals with latent tuberculosis.

The Journal of infectious diseases (2014-09-11)
Ameeta S Kalokhe, Toidi Adekambi, Chris C Ibegbu, Susan M Ray, Cheryl L Day, Jyothi Rengarajan
ABSTRACT

Human immunodeficiency virus (HIV)-infected individuals with latent Mycobacterium tuberculosis infection have substantially higher rates of progression to active tuberculosis than HIV-uninfected individuals with latent tuberculosis. To explore HIV-induced deficits in M. tuberculosis-specific CD8+ T-cell functions, we compared interferon γ production, degranulation, and proliferation of CD8+ T cells in response to M. tuberculosis peptides (ESAT-6/CFP-10) between HIV-infected (median CD4+ T-cell count, 522 cells/µL; interquartile range, 318-585 cells/µL) and HIV-uninfected individuals with latent tuberculosis from South Africa. We found that M. tuberculosis-specific degranulation and proliferative capacities were impaired in the HIV-infected group. Thus, our results suggest that HIV coinfection compromises CD8+ T-cell functions in latent tuberculosis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Diethyl azodicarboxylate solution, purum, ~40% in toluene (H-NMR)
Sigma-Aldrich
Carbon dioxide, ≥99.8%
Sigma-Aldrich
Diethyl azodicarboxylate solution, 40 wt. % in toluene
Sigma-Aldrich
Carbon-12C dioxide, 99.99 atom % 12C